XML 43 R18.htm IDEA: XBRL DOCUMENT
v3.19.3

STOCKHOLDERS' EQUITY | 9 Months Ended
--- | ---
Sep. 30, 2019
STOCKHOLDERS' EQUITY |
STOCKHOLDERS' EQUITY | 12. STOCKHOLDERS’ EQUITY Common Stock On February 9, 2018, the Company sold 9.2 million shares of common stock, par value $0.0001 per share, in a public offering at a price of $6.90 per share. The net proceeds to the Company from the offering were approximately $60.4 million, after deducting the underwriters’ discounts and offering expenses. The Company used the net proceeds, together with the net proceeds from the issuance of the Additional 2025 Notes, to fund the cash consideration for the acquisition of the West Quito Draw Properties, and for general corporate purposes, including funding the Company’s 2018 drilling program. On the Effective Date, all shares of the predecessor company were cancelled, see Note 15, “Subsequent Events” for further details related to the impact of emergence from chapter 11 bankruptcy on the Company’s equity and common stock outstanding. Warrants On September 9, 2016, the Company issued 4.7 million new warrants. The warrants could be exercised to purchase 4.7 million shares of the Company’s common stock at an exercise price of $14.04 per share. The holders were entitled to exercise the warrants in whole or in part at any time prior to expiration on September 9, 2020. On the Effective Date, all warrants of the predecessor company were cancelled, see Note 15, “Subsequent Events” for further details related to the impact of emergence from chapter 11 bankruptcy on the Company’s warrants. Incentive Plans On September 9, 2016, the Company’s Board adopted the 2016 Long-Term Incentive Plan (the Incentive Plan). An aggregate of 10.0 million shares of the Company’s common stock were available for grant pursuant to awards under the Incentive Plan. On April 6, 2017, Amendment No. 1 to the Incentive Plan to increase, by 9.0 million shares, the maximum number of shares of common stock that may be issued thereunder, i.e., a maximum of 19.0 million shares, became effective, which was 20 calendar days following the date the Company mailed an information statement to all stockholders of record notifying them of approval of the amendment by written consent of holders of a majority of the Company’s outstanding stock. As of September 30, 2019 and December 31, 2018, a maximum of 8.0 million and 4.9 million shares, respectively, of the Company’s common stock remained reserved for issuance under the Incentive Plan. Immediately prior to the Effective Date, all outstanding stock-based compensation awards granted thereunder were either vested or cancelled, see Note 15, "Subsequent Events" for further details related to the impact of emergence from chapter 11 bankruptcy. The Company accounts for stock-based payment accruals under authoritative guidance on stock compensation. The guidance requires all stock-based payments to employees and directors, including grants of stock options and restricted stock, to be recognized in the financial statements based on their fair values. The Company has elected to not apply a forfeiture estimate and will recognize a credit in compensation expense to the extent awards are forfeited. For the three and nine months ended September 30, 2019, the Company recognized a credit of $2.3 million and $8.0 million, respectively, related to stock-based compensation recorded as a component of “General and administrative” on the unaudited condensed consolidated statements of operations. During the nine months ended September 30, 2019, senior executives departed the Company. In accordance with the terms of these senior executives’ employment agreements, unvested stock options and unvested shares of restricted stock were modified to vest immediately upon termination or approval by the Bankruptcy Court. For the three and nine months ended September 30, 2019, the Company recognized incremental reductions to stock-based compensation expense of $1.1 million and $9.5 million, respectively, associated with these modifications. For the three and nine months ended September 30, 2018, the Company recognized an expense of $4.4 million and $12.2 million, respectively, related to stock-based compensation recorded as a component of "General and administrative" on the unaudited condensed consolidated statements of operations. Stock Options From time to time, the Company grants stock options under the Incentive Plan covering shares of common stock to employees of the Company. Stock options, when exercised, are settled through the payment of the exercise price in exchange for new shares of stock underlying the option. These awards typically vest over a three year period at a rate of one-third on the annual anniversary date of the grant and expire ten years from the grant date. No stock options were granted during the nine months ended September 30, 2019. At September 30, 2019, the Company had $0.2 million of unrecognized compensation expense related to non-vested stock options to be recognized over a weighted-average period of 0.8 years. During the nine months ended September 30, 2018, the Company granted stock options under the Incentive Plan covering 1.2 million shares of common stock to employees of the Company. These stock options have an exercise price of $5.65. During the nine months ended September 30, 2018, the Company received $0.3 million from the exercise of stock options. At September 30, 2018, the Company had $7.1 million of unrecognized compensation expense related to non-vested stock options to be recognized over a weighted-average period of 1.1 years. Restricted Stock From time to time, the Company grants shares of restricted stock to employees and non-employee directors of the Company. Employee shares typically vest over a three year period at a rate of one-third on the annual anniversary date of the grant, and the non-employee directors’ shares vest six months from the date of grant. During the nine months ended September 30, 2019, the Company granted 4.2 million shares of restricted stock under the Incentive Plan to employees and non-employee directors of the Company. These restricted shares were granted at prices ranging from $1.29 to $1.40 with a weighted average price of $1.29 per share. At September 30, 2019, the Company had $2.7 million of unrecognized compensation expense related to non-vested restricted stock awards to be recognized over a weighted-average period of 1.3 years. During the nine months ended September 30, 2018, the Company granted 2.3 million shares of restricted stock under the Incentive Plan to employees and non-employee directors of the Company. These restricted shares were granted at prices ranging from $3.75 to $5.65 with a weighted average price of $5.47. At September 30, 2018, the Company had $8.6 million of unrecognized compensation expense related to non-vested restricted stock awards to be recognized over a weighted-average period of 1.2 years.

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -URI http://asc.fasb.org/topic&trid=2208762 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 + Details
Name: | us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration